EBUS-TBNA proves effective for tumor molecular analysis in lung cancer

Biopsy News

EBUS-TBNA proves effective for tumor molecular analysis in lung cancer
UltrasoundCancerCancer Treatment
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 63 sec. here
  • 15 min. at publisher
  • 📊 Quality Score:
  • News: 70%
  • Publisher: 71%

Tumor molecular analysis using next-generation sequencing (NGS) is the standard of care for guiding lung cancer treatment. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive technique used to sample mediastinal lymph nodes for diagnosing and staging lung cancer.

Xia & He Publishing Inc.Oct 28 2024 Background and objectives Tumor molecular analysis using next-generation sequencing is the standard of care for guiding lung cancer treatment . Endobronchial ultrasound-guided transbronchial needle aspiration is a minimally invasive technique used to sample mediastinal lymph nodes for diagnosing and staging lung cancer . This study aimed to determine if EBUS-TBNA provided adequate tissue samples for NGS.

Methods We evaluated EBUS-TBNA samples from adult advanced non-small cell lung cancer patients who had both EBUS-TBNA and liquid biopsy samples analyzed by NGS between July 1, 2015 and June 30, 2021. Additionally, we compared the results with those from liquid biopsies performed on these patients. Results Among the 44 evaluated patients, 43% were male, with a median age of 66 years at diagnosis. Seventy-five percent were smokers, 79.5% were White, 6.8% were Black, and 9.1% were Asian. EBUS-TBNA samples were sufficient for NGS in 95.5% of cases. The median turnaround time for EBUS-TBNA NGS was 38.5 days compared with eight days for NGS in liquid biopsies. Actionable genetic aberrations were detected in 71% of patients.

Conclusions Our findings demonstrated that EBUS-TBNA provided sufficient tissue for identifying actionable genetic aberrations in patients with advanced non-small cell lung cancer.Journal reference:Brice, K., et al. . Molecular Profiling Using Next-generation Sequencing of Sufficient Endobronchial Ultrasound-guided Transbronchial Needle Aspiration and Liquid Biopsy Samples in Patients with Advanced Lung Cancer. Journal of Clinical and Translational Pathology. doi.org/10.14218/jctp.2024.00021.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Ultrasound Cancer Cancer Treatment Cell Genetic Lung Cancer Lymph Nodes Non-Small Cell Lung Cancer Pathology Research Small Cell Lung Cancer Tumor

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

HLA typing using PCR and NGS technologyHLA typing using PCR and NGS technologyNGS technology and long-range PCR enable precise HLA typing for multiple applications.
Read more »

High-quality DNA library preparation for NGS with thermal cyclersHigh-quality DNA library preparation for NGS with thermal cyclersPrecision thermal cyclers ensure accurate NGS DNA library preparation.
Read more »

Automated HLA genotyping for stem cell transplants using NGSAutomated HLA genotyping for stem cell transplants using NGSAutomated NGS improves accuracy and efficiency in HLA genotyping for transplants.
Read more »

Pediatric brain tumor research takes leap forward with CBTN dataPediatric brain tumor research takes leap forward with CBTN dataThe Gabriella Miller Kids First Data Resource Center (Kids First DRC) announces the addition of the full Children's Brain Tumor Network (CBTN) dataset to the Kids First DRC portal.
Read more »

Edaravone shows promise in targeting brain tumor stem cellsEdaravone shows promise in targeting brain tumor stem cellsGlioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.
Read more »

Molecular chaperones as key players in tumor suppressor stabilityMolecular chaperones as key players in tumor suppressor stabilityA new review was published in Oncotarget's Volume 15 on October 1, 2024, entitled, 'Molecular chaperones: Guardians of tumor suppressor stability and function.'
Read more »



Render Time: 2025-02-12 22:12:15